These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2005-000371-18||The use of Thalidomide as a treatment for the cachexia of incurable upper gastrointestinal adenocarcinomas:a randomised, double-blinded, placebo controlled trial.||not-yet-due|
|Ongoing||2005-000988-26||Cyclooxygenase inhibitor therapy in patients with oesophageal adenocarcinoma: A pilot study||not-yet-due|
|Ongoing||2005-003285-42||A RCT to test the analgesic efficacy of topical morphine on minor and partial thickness burns in A&E||not-yet-due|
|Not reported||2008-006080-36||Analgesic efficacy of ultrasound guided transversus abdominis plane block as part of a multimodal analgesic regime for post elective caesarean section pain – a comparative double-blinded placebo contr...||2015-05-01||due-trials|
|Not reported||2009-017537-21||Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial functi...||2011-07-04||due-trials|
|Ongoing||2013-001097-24||Use of N-Acetylcysteine (NAC) and Simeticone as a pre-endoscopic drink to improve mucosal visualisation during gastroscopy: A randomised controlled trial||not-yet-due|
|Ongoing||2014-002766-73||The effect of oral Vitamin D supplementation on endothelial function, vascular inflammation, oxidative stress and insulin sensitivity in patients with impaired fasting glucose: A randomised, double bl...||not-yet-due|
|Ongoing||2014-005594-36||A Phase IV, Randomised, Double-Blind, Controlled, Parallel Group Trial to Evaluate the Effectiveness and Safety of Balneum Plus vs Emollient in the Treatment of Uraemic Pruritus in Haemodialysis Patie...||not-yet-due|
|Ongoing||2017-001227-45||Comparison of ambulatory glucose profile prior to and during pancreatic enzyme replacement therapy in patients with diabetes and pancreatic exocrine insufficiency: a single-arm phase IV trial||not-yet-due|